Shares of Waystar Holding Corp (WAY) soared 7.34% in pre-market trading on Thursday following the release of its strong first-quarter 2025 results and raised full-year guidance. The healthcare technology company reported better-than-expected earnings and revenue, demonstrating resilience in a challenging economic environment.

Waystar reported Q1 non-GAAP earnings of $0.32 per diluted share, up from $0.20 a year earlier and in line with analysts' expectations. Revenue for the quarter increased 14% year-over-year to $256.4 million, surpassing the FactSet consensus estimate of $248.3 million. The company's net revenue retention rate reached an impressive 114% for the last 12 months, indicating strong client satisfaction and expansion.

In response to the robust performance, Waystar raised its full-year 2025 guidance. The company now expects non-GAAP EPS of $1.31 to $1.34 on revenue of $1.01 billion to $1.02 billion, up from its previous forecast in February. CEO Matthew Hawkins highlighted the company's focus on AI-powered solutions, stating, "We are actually moving from AI hype to ROI reality." Waystar's recent launch of AltitudeAI, a comprehensive suite of generative AI capabilities, has shown promising early results, with clients reporting significant improvements in efficiency and reimbursement outcomes.